Akshay Jadhav
@akshayjadhav0912
0 Followers
0 Following

Non Invasive Prenatal Testing Market| Market Trends by Instruments, Consumables, Method, Applicationand End User

The major factors driving the growth of this market include the growing preference for non-invasive techniques over invasive methods, rising focus on reimbursement for NIPT, launch of new and advanced NIPT products, and increasing maternal age (associated with growth in the risk of chromosomal abnormalities in babies). Furthermore, untapped emerging markets are expected to offer potential growth opportunities to players operating in the NIPT market during the forecast period.

Gas Chromatography Market |Market Analysis by Instrument, Accessories and Consumables, End User with Key Players

In this report, the gas chromatography market is segmented on the basis of instruments, accessories and consumables, end users, and regions. The instruments market is segmented into systems, detectors, auto-samplers, and fraction collectors. The systems segment is projected to register the highest CAGR during the forecast period. The growth of this segment can primarily be attributed to factors such as increased capability to analyze complex compounds and technological advancements.

Non-invasive Prenatal Testing Market :Lucrative Business Growth Opportunities

The global NIPT market is expected to reach USD 2.88 Billion by 2021 from USD 1.35 Billion in 2016, at a CAGR of 16.4% during the forecast period.

Global Glycomics Market Players Pursue the Strategies of Product Launches, Agreements, Expansions, Acquisitions, and Collaborations

The major players in this market include Agilent Technologies (U.S.), Bruker Corp. (U.S.), Danaher Corp. (U.S.), New England Biolabs (U.S.), Prozyme Inc. (U.S.), Shimadzu Corp. (Japan), Sigma-Aldrich Corp. (U.S.), Takara Bio (Japan), Thermo Fisher Scientific (U.S.), and Waters Corp. (U.S.).

GE Healthcare (U.S.), Danaher Corporation (U.S.), PerkinElmer, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), and Becton, Dickinson and Company (U.S.) Dominate the Global High-content screening Market

Thermo Fisher Scientific Inc. is one of the top players in the market. The company operates in more than 180 countries across North America, Europe, Asia, and Latin America. It offers HCS instruments and software among other products. The company focuses on product launches as its key business strategy. In May 2016, the company launched the Invitrogen Evos FL Auto 2 Imaging System to provide rapid capture and analysis of higher-quality images in live-cell imaging experiments. In addition, in January 2016, Thermo Fisher Scientific launched the Cell Insight CX7 high-content analysis platform. This strengthened the company’s hold in the HCS market.

High Content Screening Market worth $909.0 Million by 2022

The factors expected to drive the growth of the market are growth in funding for cellular research, cost containment in pharma R&D, and technological advancements in HCS solutions. The rapid growth in developing countries across APAC is also expected to provide an opportunity for revenue generation in the market. However, the high cost of HCS instruments and the dearth of knowledgeable and skilled personnel for the operation of the instruments are expected to restrain the market growth.

Pharmaceutical Robots Market worth $119.5 Million by 2021

This report segments the market based on type, application, and region. On the basis of type, the market is segmented into traditional robots and collaborative robots. The traditional robots segment is expected to command the largest share of the global market. However, the collaborative pharmaceutical robots segment is expected to register the highest CAGR of 36.6% during the forecast period. The ability to operate collaboratively with humans as well as their ability to be re-deployed easily is contributing to their growth during the forecast period.

Pharmaceutical Robots Market worth $119.5 Million by 2021

This report segments the market based on type, application, and region. On the basis of type, the market is segmented into traditional robots and collaborative robots. The traditional robots segment is expected to command the largest share of the global market. However, the collaborative pharmaceutical robots segment is expected to register the highest CAGR of 36.6% during the forecast period. The ability to operate collaboratively with humans as well as their ability to be re-deployed easily is contributing to their growth during the forecast period.

Pharmacy Automation Market worth $5.38 Billion by 2022

According to the new market research report “Pharmacy Automation System Market by Product (Medication Dispensing System (Robot, Carousel), Packaging & Labeling System (Unit Dose, Multi Dose), Tabletop Counter, Storage System), End User (Inpatient, Outpatient, Retail Pharmacy) - Global Forecast to 2022", published by MarketsandMarkets™, The global pharmacy automation market is projected to reach USD 5.38 billion by 2022, at a CAGR of 8.2% from 2017 to 2022. The market growth can be attributed to a number of factors such as the growing need to minimize medication errors, rapid decentralization of pharmacies, changing population demographics, and rising labor costs.

Gas Chromatography Market worth $3.67 Billion by 2022

New market research report "Gas Chromatography Market by Instrument (Systems, Detectors), Accessories and Consumables (Columns, Column accessories, Pressure regulators, Gas generators),End user (Oil & Gas industry, Environmental agencies, Pharma & Biotech) - Global Forecast to 2022", published by MarketsandMarkets™, The global gas chromatography market is expected to reach USD 3.67 Billion by 2022 from USD 2.64 Billion in 2016, at a CAGR of 6.2%.